MedTrace Logo

Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris

NCT01047189 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2018-09-10

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to evaluate the effectiveness of two different types of topical acne medication. This study will help to determine if one combined medication results in better acne improvement than two separate medications for acne.

Conditions

  • Acne Vulgaris

Interventions

DRUG

clindamycin phosphate 1.2% and tretinoin 0.025%

applied once daily for 12 weeks

DRUG

clindamycin 1% gel

Topical clindamycin applied each morning for 12 weeks

DRUG

tretinoin 0.025% cream

Tretinoin 0.025% cream each evening for 12 weeks

Sponsors & Collaborators

  • Medicis Pharmaceutical Corporation

    collaborator INDUSTRY

  • Wake Forest University

    lead OTHER

Principal Investigators

  • Steven R Feldman, MD, Ph.D · Wake Forest University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-10-31
Completion
2009-10-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01047189 on ClinicalTrials.gov